Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

827
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
827
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

1.2K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.2K
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

898
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
898
Antiepileptic Drugs: Calcium Channel Blockers01:17

Antiepileptic Drugs: Calcium Channel Blockers

1.2K
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
1.2K
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

1.6K
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
1.6K
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

635
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
635

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fear Memory-Triggered Sleep Disruption: Insights from Ventral Hippocampus-Basolateral Amygdala Manipulation.

Sleep·2026
Same author

Water-Bath Stunning Efficiency, Welfare Indicators, and Carcass Quality in Taiwanese Red-Feathered Native Chickens.

Veterinary sciences·2026
Same author

Effects of Sulbactam on behavioral and neuronal deficits in an MPTP-induced Parkinson's disease rat model.

Brain research bulletin·2026
Same author

Dasatinib boosts γδ T cell expansion and memory phenotypes with enhanced antitumor immunity.

Cancer immunology, immunotherapy : CII·2026
Same author

<i>Hedyotis diffusa</i> Suppresses Colitis-Associated Colorectal Cancer via Inhibition of the IL-17A-IL-17RA Axis and NF-κB Signaling.

International journal of molecular sciences·2026
Same author

Resveratrol Supplementation and its Potential Benefits in Obesity-related Non-communicable Diseases.

In vivo (Athens, Greece)·2026

Related Experiment Video

Updated: Jan 16, 2026

Electrophoretic Delivery of &#947;-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
07:01

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

9.4K

Sulbactam: A β-Lactam Compound with Neuroprotective Effects in Epilepsy.

Fang-Chia Chang1,2,3, Chiung-Hui Liu4,5, Wen-Chieh Liao4,5

  • 1Department of Veterinary Medicine, School of Veterinary Medicine, National Taiwan University, Taipei 10617, Taiwan.

Neurology International
|September 26, 2025
PubMed
Summary

Sulbactam (SUL) shows promise for epilepsy treatment by increasing glutamate transporter-1 (GLT-1) expression and promoting astrocyte proliferation, which reduces neuronal hyperactivity and seizures.

Keywords:
astrocytecognitive functionepilepsyglutamateseizuresulbactam

More Related Videos

Preparation of Acute Human Hippocampal Slices for Electrophysiological Recordings
07:31

Preparation of Acute Human Hippocampal Slices for Electrophysiological Recordings

Published on: May 7, 2020

7.9K
Lipidomics and Transcriptomics in Neurological Diseases
09:58

Lipidomics and Transcriptomics in Neurological Diseases

Published on: March 18, 2022

3.9K

Related Experiment Videos

Last Updated: Jan 16, 2026

Electrophoretic Delivery of &#947;-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
07:01

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

9.4K
Preparation of Acute Human Hippocampal Slices for Electrophysiological Recordings
07:31

Preparation of Acute Human Hippocampal Slices for Electrophysiological Recordings

Published on: May 7, 2020

7.9K
Lipidomics and Transcriptomics in Neurological Diseases
09:58

Lipidomics and Transcriptomics in Neurological Diseases

Published on: March 18, 2022

3.9K

Area of Science:

  • Neuroscience
  • Pharmacology

Background:

  • Epilepsy pathophysiology involves glutamate excitotoxicity and GABA deficiency.
  • Astrocytes regulate neuronal excitation via glutamate transporter-1 (GLT-1).
  • Sulbactam (SUL) upregulates GLT-1, offering neuroprotection.

Purpose of the Study:

  • Investigate SUL's effects on neuronal and behavioral changes in a PTZ-induced epilepsy rat model.
  • Assess SUL's impact on GLT-1 expression and astrocyte activity.

Main Methods:

  • Rats received saline, SUL (50 or 150 mg/kg), or SUL + dihydrokainate (DHK) for 20 days.
  • Behavioral tests evaluated recognition, anxiety, and memory.
  • Histological analysis examined neuronal integrity and STN activity.

Main Results:

  • SUL treatment ameliorated neuronal deficits and STN hyperactivity.
  • SUL increased astrocytic GLT-1 expression and promoted astrocyte proliferation.
  • The neuroprotective effects of SUL were blocked by DHK.

Conclusions:

  • SUL demonstrates significant neuroprotective benefits in an epilepsy model.
  • SUL suppresses seizures, upregulates GLT-1, and enhances astrocyte proliferation.
  • SUL presents high potential as an epilepsy therapeutic agent.